Literature DB >> 23538449

Alcohol screening scores and 90-day outcomes in patients with acute lung injury.

Brendan J Clark1, André Williams, Laura M Cecere Feemster, Katharine A Bradley, Madison Macht, Marc Moss, Ellen L Burnham.   

Abstract

OBJECTIVES: The effects of excess alcohol consumption (alcohol misuse) on outcomes in patients with acute lung injury have been inconsistent, and there are no studies examining this association in the era of low tidal volume ventilation and a fluid conservative strategy. We sought to determine whether validated scores on the Alcohol Use Disorders Identification Test that correspond to past-year abstinence (zone 1), low-risk drinking (zone 2), mild to moderate alcohol misuse (zone 3), and severe alcohol misuse (zone 4) are associated with poor outcomes in patients with acute lung injury.
DESIGN: Secondary analysis.
SETTING: The Acute Respiratory Distress Syndrome Network, a consortium of 12 university centers (44 hospitals) dedicated to the conduct of multicenter clinical trials in patients with acute lung injury.
SUBJECTS: Patients meeting consensus criteria for acute lung injury enrolled in one of three recent Acute Respiratory Distress Syndrome Network clinical trials.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 1,133 patients enrolled in one of three Acute Respiratory Distress Syndrome Network studies, 1,037 patients had an Alcohol Use Disorders Identification Test score available for analysis. Alcohol misuse was common with 70 (7%) of patients having Alcohol Use Disorders Identification Test scores in zone 3 and 129 (12%) patients in zone 4. There was a U-shaped association between validated Alcohol Use Disorders Identification Test zones and death or persistent hospitalization at 90 days (34% in zone 1, 26% in zone 2, 27% in zone 3, 36% in zone 4; p < 0.05 for comparison of zone 1 to zone 2 and zone 4 to zone 2). In a multiple logistic regression model, there was a significantly higher odds of death or persistent hospitalization in patients having Alcohol Use Disorders Identification Test zone 4 compared with those in zone 2 (adjusted odds ratio 1.70; 95% confidence interval 1.00, 2.87; p = 0.048).
CONCLUSIONS: Severe but not mild to moderate alcohol misuse is independently associated with an increased risk of death or persistent hospitalization at 90 days in acute lung injury patients.

Entities:  

Mesh:

Year:  2013        PMID: 23538449      PMCID: PMC4048714          DOI: 10.1097/CCM.0b013e318287f1bb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  56 in total

Review 1.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

2.  Increased alveolar epithelial permeability in cigarette smokers.

Authors:  J G Jones; B D Minty; P Lawler; G Hulands; J C Crawley; N Veall
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

3.  Mechanisms of cigarette smoke induced increased airspace permeability.

Authors:  X Y Li; I Rahman; K Donaldson; W MacNee
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

Authors:  J Deviere; J Content; C Denys; P Vandenbussche; L Schandene; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

6.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

7.  Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome.

Authors:  E R Pacht; A P Timerman; M G Lykens; A J Merola
Journal:  Chest       Date:  1991-11       Impact factor: 9.410

8.  Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract.

Authors:  C D Spies; A Nordmann; G Brummer; C Marks; C Conrad; G Berger; N Runkel; T Neumann; C Müller; H Rommelspacher; M Specht; L Hannemann; H W Striebel; W Schaffartzik
Journal:  Acta Anaesthesiol Scand       Date:  1996-07       Impact factor: 2.105

9.  The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults.

Authors:  M Moss; B Bucher; F A Moore; E E Moore; P E Parsons
Journal:  JAMA       Date:  1996-01-03       Impact factor: 56.272

10.  Adverse influence of cigarette smoking on the endothelium.

Authors:  A D Blann; C N McCollum
Journal:  Thromb Haemost       Date:  1993-10-18       Impact factor: 5.249

View more
  17 in total

1.  Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.

Authors:  Tasha Barr; Thomas Girke; Suhas Sureshchandra; Christina Nguyen; Kathleen Grant; Ilhem Messaoudi
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

2.  The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.

Authors:  Jeanette Gaydos; Alicia McNally; Ellen L Burnham
Journal:  Alcohol       Date:  2018-09-05       Impact factor: 2.405

3.  Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity.

Authors:  Mehdi A Fini; Jeanette Gaydos; Alicia McNally; Vijaya Karoor; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

4.  Cut-Point Levels of Phosphatidylethanol to Identify Alcohol Misuse in a Mixed Cohort Including Critically Ill Patients.

Authors:  Majid Afshar; Ellen L Burnham; Cara Joyce; Brendan J Clark; Meagan Yong; Jeannette Gaydos; Richard S Cooper; Gordon S Smith; Elizabeth J Kovacs; Erin M Lowery
Journal:  Alcohol Clin Exp Res       Date:  2017-09-13       Impact factor: 3.455

Review 5.  Alcohol and lung injury and immunity.

Authors:  Samantha M Yeligar; Michael M Chen; Elizabeth J Kovacs; Joseph H Sisson; Ellen L Burnham; Lou Ann S Brown
Journal:  Alcohol       Date:  2016-09-16       Impact factor: 2.405

6.  The respiratory tract microbial biogeography in alcohol use disorder.

Authors:  Derrick R Samuelson; Ellen L Burnham; Vincent J Maffei; R William Vandivier; Eugene E Blanchard; Judd E Shellito; Meng Luo; Christopher M Taylor; David A Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

7.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

8.  Alcohol screening scores and the risk of intensive care unit admission and hospital readmission.

Authors:  Brendan J Clark; Anna D Rubinsky; P Michael Ho; David H Au; Laura J Chavez; Marc Moss; Katharine A Bradley
Journal:  Subst Abus       Date:  2016-01-05       Impact factor: 3.716

9.  Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome.

Authors:  S Jean Hsieh; Hanjing Zhuo; Neal L Benowitz; B Taylor Thompson; Kathleen D Liu; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

10.  Salvianolic acid B attenuates lipopolysaccharide-induced acute lung injury in rats through inhibition of apoptosis, oxidative stress and inflammation.

Authors:  Da-Hai Zhao; Yu-Jie Wu; Shu-Ting Liu; Rong-Yu Liu
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.